Treatment of inflammatory bowel disease: a review of medical therapy.
about
Oral budesonide for induction of remission in ulcerative colitisOral budesonide for induction of remission in ulcerative colitisShort chain fatty acids (butyrate) for induction of remission in ulcerative colitisStructural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgeryBioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and PitfallsCancer prevention with promising natural products: mechanisms of action and molecular targetsSelective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitroMetagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis.Insight into the pharmacokinetic behavior of tanshinone IIA in the treatment of Crohn's disease: comparative data for tanshinone IIA and its two glucuronidated metabolites in normal and recurrent colitis models after oral administration.Activation of TGF-β activated kinase 1 promotes colon mucosal pathogenesis in inflammatory bowel disease.Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in ratsTreating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Iridoid glycosides fraction of Folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis.B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative miceLITAF mediation of increased TNF-α secretion from inflamed colonic lamina propria macrophages.Temporal colonic gene expression profiling in the recurrent colitis model identifies early and chronic inflammatory processes.Anti-inflammatory Effects of Flavonoids on TNBS-induced Colitis of RatsEfficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative ColitisIncreased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease.Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease.Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of miceEffect of hydroalcoholic extract of Hibiscus rosa sinensis Linn. leaves in experimental colitis in rats.Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosisApplication of prodrugs to inflammatory diseases of the gut.Effect of the C3435T polymorphism of the multidrug resistance 1 gene on the severity of inflammatory bowel disease in Iranian Azeri Turks.Treatment of choice for acute severe steroid-refractory ulcerative colitis is colectomy.Comparative effectiveness of infliximab and adalimumab for Crohn's disease.Common Pitfalls in Management of Inflammatory Bowel Disease.Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.Association of plasminogen activator inhibitor-1 gene polymorphism with inflammatory bowel disease in Iranian Azeri Turkish patients.Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations.Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkersHow the discovery of TNF-α has advanced gastrointestinal diseases and treatment regimes.Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.Targeted localized use of therapeutic antibodies: a review of non-systemic, topical and oral applications.Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitisChanges in the approach to acute diverticulitis.An experimental model of colitis induced by dextran sulfate sodium from acute progresses to chronicity in C57BL/6: correlation between conditions of mice and the environment.
P2860
Q24186368-56A52B80-0257-4A0C-85C2-A994DD28E952Q24234633-6E05F5CE-B339-4052-ADDF-5A1455A8B779Q24234780-543F5277-E369-48A1-B603-2757842514E9Q24658549-00AE68B1-61FB-45D5-90D9-7E7A40412C6AQ26740337-3C536E41-2C34-4929-A913-FBDFCFA2BCFBQ27006530-7B651793-4752-47FA-8A65-22DA6FD820DCQ28479065-958D3655-D335-4D57-B0CA-FDD9BAE0F699Q30920058-E2EC9ED3-931D-4F6A-B620-D3AE26928DD8Q31068601-A0B7458C-39E6-4ED0-B204-BD3C11B49FF6Q33567451-1DE6C0CE-37C8-4C58-8120-66915CBFF8BFQ33626027-81852CB7-3C75-4A3C-8DFB-DDD1582D452EQ33805567-688F1650-8647-4E54-9CC2-E6D8015BF612Q34008773-EBADCEF0-44CD-4756-B8C5-E6750CF716E4Q34024008-9DC1E790-3502-40BF-830E-56468E83CE80Q34035218-0F0BE50C-6C4E-4FBC-8324-9B352AD8376CQ34045034-84DA9246-F87B-41C0-8A87-EC6F7D993B11Q34505311-81262DE9-2554-4577-BD3A-A95D7C6E04C0Q34980451-78FD00D1-52A6-48AA-A47C-A230688508A4Q35777883-91EB0568-E967-42B9-884F-CC6C4162E211Q36067567-8D2CD0C4-7C7A-4667-9704-F57C4E4EE495Q36265369-086B5E41-033A-4C39-AC61-9555D04A2849Q36428563-32E6AAA2-9D51-4B21-80CF-43B2F4C19107Q36719721-4B44CA4B-1E2D-4510-98CA-3799C776DC34Q36857579-2F829E4C-E9F7-4C3D-9E61-BD2C5FB41413Q37096512-11285916-F340-4754-8FFB-FACBB8F8073EQ37100443-836119B7-6554-4F87-B439-8611568BD2C1Q37325645-B848047F-B593-4391-A3ED-53F11237BE0CQ37445629-8CD330DF-65C6-4E83-8240-5870718BD46CQ37477531-FC3D9BB9-CEF0-4440-A744-268F7E0A0E3EQ37600339-87C14368-64C7-4E87-8BB9-90360F76333CQ37634825-EE754422-EBB5-45C4-9EA5-365E6124C42DQ37660708-DD4C6491-3C06-4346-A6EA-33CD8689A25FQ38029557-EC899D6D-C0D2-47E8-9ED3-71E62235683AQ38083084-0CEB8267-3755-4876-B7A2-DC51BCC6375EQ38185950-20524C93-12B8-46DA-AEEB-C4A2BF90D2B8Q38196945-FB85DEE4-33C8-46DE-8C45-115837FB23E1Q38323786-63DAEE61-889B-4112-BB88-1F881823E60FQ38399146-B763EEAC-9FF0-4586-9FE1-66B9674D08F4Q38554576-B09FA246-0EC4-4707-8B54-6DCA42CEDBADQ38923121-30183DAA-BA9E-42F0-A331-56DD133E810D
P2860
Treatment of inflammatory bowel disease: a review of medical therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of inflammatory bowel disease: a review of medical therapy.
@en
Treatment of inflammatory bowel disease: a review of medical therapy.
@nl
type
label
Treatment of inflammatory bowel disease: a review of medical therapy.
@en
Treatment of inflammatory bowel disease: a review of medical therapy.
@nl
prefLabel
Treatment of inflammatory bowel disease: a review of medical therapy.
@en
Treatment of inflammatory bowel disease: a review of medical therapy.
@nl
P2860
P356
P1476
Treatment of inflammatory bowel disease: a review of medical therapy.
@en
P2093
Patricia L Kozuch
Stephen B Hanauer
P2860
P304
P356
10.3748/WJG.14.354
P407
P577
2008-01-01T00:00:00Z